Biochemical hallmarks of tyrosine hydroxylase deficiency

Author(s): Bräutigam C, Wevers RA, Jansen RJ, Smeitink JA, de Rijk-van Andel JF, et al.

Abstract

We report the biochemical hallmarks of tyrosine hydroxylase deficiency with emphasis on reliable diagnostic strategies of four new cases of an inborn error of tyrosine hydroxylase (TH). Three of our patients from different parts of the Netherlands were found homozygous for a mutation in exon 6 (G698A) of the TH gene, and one patient was found compound heterozygous for the same mutation and an additional mutation in exon 3. The first clinical symptoms of hypokinesia, rigidity of arms and legs and axial hypotonia, developed between 3 and 7 months of age. Cerebrospinal fluid investigations revealed a characteristic metabolite constellation in every case: low homovanillic acid (HVA) and 3-methoxy-4-hydroxyphenylethyleneglycol concentrations in the presence of normal reference range 5-hydroxyindolacetic acid concentrations. Strict adherence to a standardized lumbar puncture protocol and adequate age-related reference values are essential for diagnosis of this "new" treatable neurometabolic disorder. Urinary measurements of HVA, vanillylmandelic acid, and catecholamines can lead to false-negative conclusions. All patients showed a remarkable clinical improvement on a low dose of L-dihydroxyphenylalanine/ (S)-2-(3,4-dihydroxybenzyl)-2-hydrazinpropionic acid. During treatment, cerebrospinal fluid HVA, and 3-methoxy-4-hydroxy-phenylethyleneglycol increased substantially.

Similar Articles

Myoclonus-dystonia syndrome

Author(s): Nardocci N

Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers

Author(s): Hess CW, Raymond D, AguiarPde C, Frucht S, Shriberg J, et al.

A novel locus for inherited myoclonus-dystonia on 18p11

Author(s): Grimes DA, Han F, Lang AE, St George-Hyssop P, Racacho L, et al.

Association of a missense change in the D2 dopamine receptor with myoclonus dystonia

Author(s): Klein C, Brin MF, Kramer P, Sena-Esteves M, de Leon D, et al.

Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity

Author(s): Valente EM, Misbahuddin A, Brancati F, Placzek MR, Garavaglia B, et al.

The diversity of GABAA receptors

Author(s): Hevers W, Lüddens H

[Why benzodiazepines are still in wide use?]

Author(s): Vlastelica M, Jelaska M

Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency

Author(s): Stamelou M, Mencacci NE, Cordivari C, Batla A, Wood NW, et al.

Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia

Author(s): Hoffmann GF, Assmann B, Bräutigam C, Dionisi-Vici C, Häussler M, et al.

Surgical treatment of myoclonus dystonia syndrome

Author(s): Rughani AI, Lozano AM